BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology. 2003;38:1188-1198. [PMID: 14578857 DOI: 10.1053/jhep.2003.50472] [Cited by in Crossref: 323] [Cited by in F6Publishing: 296] [Article Influence: 17.9] [Reference Citation Analysis]
Number Citing Articles
1 Matsusaka Y, Nakahara T, Takahashi K, Iwabuchi Y, Nakamura S, Jinzaki M. Development of 68Ga-labeled tin colloids for evaluating phagocytic function of Kupffer cells using preclinical PET imaging. Ann Nucl Med 2020;34:807-14. [PMID: 32749578 DOI: 10.1007/s12149-020-01505-3] [Reference Citation Analysis]
2 Iida A, Yoshidome H, Shida T, Takano S, Takeuchi D, Kimura F, Shimizu H, Ohtsuka M, Miyazaki M. Hepatocyte nuclear factor-kappa beta (NF-kappaB) activation is protective but is decreased in the cholestatic liver with endotoxemia. Surgery 2010;148:477-89. [PMID: 20227101 DOI: 10.1016/j.surg.2010.01.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kemelo MK, Pierzynová A, Kutinová Canová N, Kučera T, Farghali H. The involvement of sirtuin 1 and heme oxygenase 1 in the hepatoprotective effects of quercetin against carbon tetrachloride-induced sub-chronic liver toxicity in rats. Chemico-Biological Interactions 2017;269:1-8. [DOI: 10.1016/j.cbi.2017.03.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
4 Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 2004;40:414-23. [PMID: 15368446 DOI: 10.1002/hep.20301] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
5 Qin L, Shi H, Xia H, Chen L, Yao Q, Chen K. Comparative proteomic analysis of midgut proteins from male and female Bombyx mori (Lepidoptera: Bombycidae). J Insect Sci 2014;14:226. [PMID: 25502033 DOI: 10.1093/jisesa/ieu088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Ma WT, Jia YJ, Liu QZ, Yang YQ, Yang JB, Zhao ZB, Yang ZY, Shi QH, Ma HD, Gershwin ME, Lian ZX. Modulation of liver regeneration via myeloid PTEN deficiency. Cell Death Dis 2017;8:e2827. [PMID: 28542148 DOI: 10.1038/cddis.2017.47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Bechmann LP, Marquitan G, Jochum C, Saner F, Gerken G, Canbay A. Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure. Liver Int. 2008;28:713-716. [PMID: 18433398 DOI: 10.1111/j.1478-3231.2007.01566.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 23] [Article Influence: 0.4] [Reference Citation Analysis]
8 Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver. 2012;6:149-171. [PMID: 22570745 DOI: 10.5009/gnl.2012.6.2.149] [Cited by in Crossref: 247] [Cited by in F6Publishing: 231] [Article Influence: 27.4] [Reference Citation Analysis]
9 Bechmann LP, Zahn D, Gieseler RK, Fingas CD, Marquitan G, Jochum C, Gerken G, Friedman SL, Canbay A. Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells. Hepatol Res 2009;39:601-8. [PMID: 19207580 DOI: 10.1111/j.1872-034X.2008.00485.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
10 Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y, Masuoka HC, Howe CL, Gores GJ. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology. 2008;47:1317-1330. [PMID: 18220275 DOI: 10.1002/hep.22136] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
11 Schattenberg JM, Galle PR, Schuchmann M. Apoptosis in liver disease. Liver Int 2006;26:904-11. [DOI: 10.1111/j.1478-3231.2006.01324.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 5.4] [Reference Citation Analysis]
12 Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8:3895-3932. [PMID: 27965466 DOI: 10.18632/oncotarget.13904] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 22.3] [Reference Citation Analysis]
13 Satake S, Nagaki M, Kimura K, Moriwaki H. Inhibition of nuclear factor-kappa B induces inflammatory cell migration and exacerbates severe liver injury in hepatitis B virus transgenic mice. Hepatol Res 2007;37:524-30. [PMID: 17539995 DOI: 10.1111/j.1872-034X.2007.00083.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Yu X, Zhou L, Deng Q, Chen X, Tan Q, Lu H, Wei X, Hu W, Bai M, Zhou L, Yu Y, Tang Z, Yu Y, Hu J. rhIL-1Ra reduces hepatocellular apoptosis in mice with acute liver failure mainly by inhibiting the activities of Kupffer cells. Eur J Pharmacol 2019;854:338-46. [PMID: 30902658 DOI: 10.1016/j.ejphar.2019.03.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Morita Y, Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Takeuchi D, Mitsuhashi N, Iida A, Miyazaki M. Excessive inflammation but decreased immunological response renders liver susceptible to infection in bile duct ligated mice. J Surg Res 2008;146:262-70. [PMID: 18061617 DOI: 10.1016/j.jss.2007.05.040] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
16 García-Monzón C, Lo Iacono O, Mayoral R, González-Rodríguez A, Miquilena-Colina ME, Lozano-Rodríguez T, García-Pozo L, Vargas-Castrillón J, Casado M, Boscá L. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. J Hepatol. 2011;54:142-152. [PMID: 20888662 DOI: 10.1016/j.jhep.2010.06.021] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
17 Tran TT, Groben P, Pisetsky DS. The release of DNA into the plasma of mice following hepatic cell death by apoptosis and necrosis. Biomarkers 2008;13:184-200. [DOI: 10.1080/13547500701791719] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
18 Isayama F, Moore S, Hines IN, Wheeler MD. Fas Regulates Macrophage Polarization and Fibrogenic Phenotype in a Model of Chronic Ethanol-Induced Hepatocellular Injury. Am J Pathol 2016;186:1524-36. [PMID: 27102767 DOI: 10.1016/j.ajpath.2016.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
19 Woolbright BL, Jaeschke H. Therapeutic targets for cholestatic liver injury. Expert Opin Ther Targets 2016;20:463-75. [PMID: 26479335 DOI: 10.1517/14728222.2016.1103735] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
20 Nalapareddy P, Schüngel S, Hong JY, Manns MP, Jaeschke H, Vogel A. The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis. Am J Pathol. 2009;175:1077-1085. [PMID: 19661444 DOI: 10.2353/ajpath.2009.090304] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
21 Ma Y, Yang M, He Z, Wei Q, Li J. The Biological Function of Kupffer Cells in Liver Disease. In: Ghosh A, editor. Biology of Myelomonocytic Cells. InTech; 2017. [DOI: 10.5772/67673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Czaja AJ. Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci. 2015;60:2881-2900. [PMID: 25999246 DOI: 10.1007/s10620-015-3708-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
23 Kawaratani H, Tsujimoto T, Kitazawa T, Yoshiji H, Uemura M, Fukui H. Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model. J Gastroenterol Hepatol 2011;26:775-83. [PMID: 21251062 DOI: 10.1111/j.1440-1746.2011.06658.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
24 Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89:1269-1339. [PMID: 19789382 DOI: 10.1152/physrev.00027.2008] [Cited by in Crossref: 287] [Cited by in F6Publishing: 287] [Article Influence: 23.9] [Reference Citation Analysis]
25 Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012;3:56. [PMID: 23091461 DOI: 10.3389/fphys.2012.00056] [Cited by in Crossref: 141] [Cited by in F6Publishing: 146] [Article Influence: 15.7] [Reference Citation Analysis]
26 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 346] [Article Influence: 49.6] [Reference Citation Analysis]
27 Horvat T, Landesmann B, Lostia A, Vinken M, Munn S, Whelan M. Adverse outcome pathway development from protein alkylation to liver fibrosis. Arch Toxicol 2017;91:1523-43. [PMID: 27542122 DOI: 10.1007/s00204-016-1814-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
28 Sowa JP, Heider D, Bechmann LP, Gerken G, Hoffmann D, Canbay A. Novel algorithm for non-invasive assessment of fibrosis in NAFLD. PLoS One 2013;8:e62439. [PMID: 23638085 DOI: 10.1371/journal.pone.0062439] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
29 Wu R, Nakatsu G, Zhang X, Yu J. Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis. Expert Opin Ther Targets. 2016;20:615-626. [PMID: 26609894 DOI: 10.1517/14728222.2016.1125883] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
30 Han Z, Zhu T, Liu X, Li C, Yue S, Liu X, Yang L, Yang L, Li L. 15-deoxy-Δ12,14 -prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice. Hepatology 2012;56:350-60. [PMID: 22371273 DOI: 10.1002/hep.25672] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
31 Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 2008;47:1495-1503. [PMID: 18220271 DOI: 10.1002/hep.22183] [Cited by in Crossref: 179] [Cited by in F6Publishing: 164] [Article Influence: 13.8] [Reference Citation Analysis]
32 Takahashi H, Shigefuku R, Maeyama S, Suzuki M. Cirrhosis improvement to alcoholic liver fibrosis after passive abstinence. BMJ Case Rep 2014;2014:bcr2013201618. [PMID: 24414184 DOI: 10.1136/bcr-2013-201618] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
33 Peng Y, Sigua CA, Karsonovich C, Murr MM. Protein Kinase C-Zeta (PKC-ζ) Regulates Kupffer Cell Apoptosis During Experimental Sepsis. J Gastrointest Surg 2007;11:1712-21. [DOI: 10.1007/s11605-007-0314-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
34 Dini L, Vergallo C. Environmental Factors Affecting Phagocytosis of Dying Cells:Smoking and Static Magnetic Fields. In: Krysko DV, Vandenabeele P, editors. Phagocytosis of Dying Cells: From Molecular Mechanisms to Human Diseases. Dordrecht: Springer Netherlands; 2009. pp. 409-38. [DOI: 10.1007/978-1-4020-9293-0_15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
35 Macías-Rodríguez RU, Inzaugarat ME, Ruiz-Margáin A, Nelson LJ, Trautwein C, Cubero FJ. Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis-A Novel Form of Non-Apoptotic Cell Death?Int J Mol Sci. 2020;21. [PMID: 32121273 DOI: 10.3390/ijms21051651] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
36 Katsarou A, Moustakas II, Pyrina I, Lembessis P, Koutsilieris M, Chatzigeorgiou A. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(17): 1993-2011 [PMID: 32536770 DOI: 10.3748/wjg.v26.i17.1993] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
37 Piaggio F, Kondylis V, Pastorino F, Di Paolo D, Perri P, Cossu I, Schorn F, Marinaccio C, Murgia D, Daga A, Raggi F, Loi M, Emionite L, Ognio E, Pasparakis M, Ribatti D, Ponzoni M, Brignole C. A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects. J Control Release 2016;223:165-77. [PMID: 26742942 DOI: 10.1016/j.jconrel.2015.12.037] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
38 Sitia G, Iannacone M, Aiolfi R, Isogawa M, van Rooijen N, Scozzesi C, Bianchi ME, von Andrian UH, Chisari FV, Guidotti LG. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog 2011;7:e1002061. [PMID: 21655107 DOI: 10.1371/journal.ppat.1002061] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 8.1] [Reference Citation Analysis]
39 郑乔丹, 吴文苑, 陈月. 肿瘤相关巨噬细胞在肝癌细胞生长和转移中的作用. 世界华人消化杂志 2012; 20(30): 2907-2912 [DOI: 10.11569/wcjd.v20.i30.2907] [Reference Citation Analysis]
40 Anan A, Baskin-Bey ES, Isomoto H, Mott JL, Bronk SF, Albrecht JH, Gores GJ. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse. Am J Physiol Gastrointest Liver Physiol. 2006;291:G709-G716. [PMID: 16798723 DOI: 10.1152/ajpgi.00126.2006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
41 Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW, Tracy TF Jr, Gregory SH. Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology. 2006;130:810-822. [PMID: 16530521 DOI: 10.1053/j.gastro.2005.11.015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 5.7] [Reference Citation Analysis]
42 Hu L, Chen L, Li L, Sun H, Yang G, Chang Y, Tu Q, Wu M, Wang H. Hepatitis B virus X protein enhances cisplatin-induced hepatotoxicity via a mechanism involving degradation of Mcl-1. J Virol 2011;85:3214-28. [PMID: 21228225 DOI: 10.1128/JVI.01841-10] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
43 Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J. 2008;411:1-18. [PMID: 18333835 DOI: 10.1042/bj20071570] [Cited by in Crossref: 217] [Cited by in F6Publishing: 110] [Article Influence: 16.7] [Reference Citation Analysis]
44 Hevia H, Varela-Rey M, Corrales FJ, Berasain C, Martínez-Chantar ML, Latasa MU, Lu SC, Mato JM, García-Trevijano ER, Avila MA. 5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology 2004;39:1088-98. [PMID: 15057913 DOI: 10.1002/hep.20154] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
45 Privalova LI, Katsnelson BA, Loginova NV, Gurvich VB, Shur VY, Valamina IE, Makeyev OH, Sutunkova MP, Minigalieva IA, Kireyeva EP, Rusakov VO, Tyurnina AE, Kozin RV, Meshtcheryakova EY, Korotkov AV, Shuman EA, Zvereva AE, Kostykova SV. Subchronic toxicity of copper oxide nanoparticles and its attenuation with the help of a combination of bioprotectors. Int J Mol Sci 2014;15:12379-406. [PMID: 25026171 DOI: 10.3390/ijms150712379] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
46 Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H. The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2013;2013:495156. [PMID: 24385684 DOI: 10.1155/2013/495156] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 13.9] [Reference Citation Analysis]
47 Hatano M, Sasaki S, Ohata S, Shiratsuchi Y, Yamazaki T, Nagata K, Kobayashi Y. Effects of Kupffer cell-depletion on Concanavalin A-induced hepatitis. Cellular Immunology 2008;251:25-30. [DOI: 10.1016/j.cellimm.2008.02.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
48 Tahara J, Shimizu K, Shiratori K. Engulfment of necrotic acinar cells by pancreatic stellate cells inhibits pancreatic fibrogenesis. Pancreas. 2008;37:69-74. [PMID: 18580447 DOI: 10.1097/mpa.0b013e318160a5cb] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
49 Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7312-7324 [PMID: 24966602 DOI: 10.3748/wjg.v20.i23.7312] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 178] [Article Influence: 28.9] [Reference Citation Analysis]
50 He W, Ni W, Zhao L, Wang X, Liu L, Fan Z. MicroRNA-125a/VDR axis impaired autophagic flux and contributed to fibrosis in a CCL4-induced mouse model and patients with liver cirrhosis. Life Sci 2021;264:118666. [PMID: 33130085 DOI: 10.1016/j.lfs.2020.118666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
51 Vansaun MN, Mendonsa AM, Lee Gorden D. Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease. PLoS One. 2013;8:e73054. [PMID: 24039859 DOI: 10.1371/journal.pone.0073054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
52 Li H, Zhou Y, Wang H, Zhang M, Qiu P, Zhang M, Zhang R, Zhao Q, Liu J. Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. Front Immunol 2020;11:1169. [PMID: 32670278 DOI: 10.3389/fimmu.2020.01169] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
53 Aizawa S, Brar G, Tsukamoto H. Cell Death and Liver Disease. Gut Liver 2020;14:20-9. [PMID: 30917630 DOI: 10.5009/gnl18486] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
54 Capone F, Guerriero E, Sorice A, Maio P, Colonna G, Castello G, Costantini S. Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients. Clin Biochem 2012;45:525-9. [PMID: 22366372 DOI: 10.1016/j.clinbiochem.2012.02.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
55 Puellmann K, Beham A, Kienle K, Vogel M, Schlitt HJ, Jauch KW, Rentsch M. Inhibition of Apoptosis Reduces Immunogeneic Potential of Adenoviral-Treated Syngeneic Liver Grafts: . Transplantation 2006;82:1377-82. [DOI: 10.1097/01.tp.0000235815.44258.a8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Lee TF, Lin YL, Huang YT. Kaerophyllin inhibits hepatic stellate cell activation by apoptotic bodies from hepatocytes. Liver Int 2011;31:618-29. [PMID: 21457435 DOI: 10.1111/j.1478-3231.2011.02485.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
57 Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Mühllechner P, Habior A, Graziadei I, Vogel W, Tilg H. The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol. 2005;43:973-983. [PMID: 16143421 DOI: 10.1016/j.jhep.2005.05.034] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
58 Chiabotto G, Pasquino C, Camussi G, Bruno S. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis. Front Cell Dev Biol 2020;8:594794. [PMID: 33425900 DOI: 10.3389/fcell.2020.594794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
59 Mazzolini G, Sowa J, Canbay A. Cell death mechanisms in human chronic liver diseases: a far cry from clinical applicability. Clinical Science 2016;130:2121-38. [DOI: 10.1042/cs20160035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
60 Minigalieva IA, Katsnelson BA, Privalova LI, Sutunkova MP, Gurvich VB, Shur VY, Shishkina EV, Valamina IE, Makeyev OH, Panov VG, Varaksin AN, Grigoryeva EV, Meshtcheryakova EY. Attenuation of Combined Nickel(II) Oxide and Manganese(II, III) Oxide Nanoparticles' Adverse Effects with a Complex of Bioprotectors. Int J Mol Sci 2015;16:22555-83. [PMID: 26393577 DOI: 10.3390/ijms160922555] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 8.2] [Reference Citation Analysis]
61 Wei X, Wei H, Lin W, Hu Z, Zhang J. Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy. Medicine (Baltimore) 2017;96:e6807. [PMID: 28514295 DOI: 10.1097/MD.0000000000006807] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
62 Nabih ES, El-kharashi OA. Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation. Naunyn-Schmiedeberg's Arch Pharmacol 2019;392:37-43. [DOI: 10.1007/s00210-018-1560-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Elmarakby DM, Sourour DA. The effect of Nigella sativa on the diabetic liver in male albino rats with a special focus on the role of hepatic oval cells: . The Egyptian Journal of Histology 2012;35:749-60. [DOI: 10.1097/01.ehx.0000420213.66657.1d] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Alharthi J, Latchoumanin O, George J, Eslam M. Macrophages in metabolic associated fatty liver disease. World J Gastroenterol 2020; 26(16): 1861-1878 [PMID: 32390698 DOI: 10.3748/wjg.v26.i16.1861] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
65 An L, Wang X, Cederbaum AI. Cytokines in alcoholic liver disease. Arch Toxicol. 2012;86:1337-1348. [PMID: 22367091 DOI: 10.1007/s00204-012-0814-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 8.7] [Reference Citation Analysis]
66 Kumagai K, Kiyosawa N, Ito K, Yamoto T, Teranishi M, Nakayama H, Manabe S. Influence of Kupffer cell inactivation on cycloheximide-induced hepatic injury. Toxicology 2007;241:106-18. [PMID: 17900782 DOI: 10.1016/j.tox.2007.08.090] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
67 Ganesan M, Natarajan SK, Zhang J, Mott JL, Poluektova LI, McVicker BL, Kharbanda KK, Tuma DJ, Osna NA. Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde. Am J Physiol Gastrointest Liver Physiol 2016;310:G930-40. [PMID: 27056722 DOI: 10.1152/ajpgi.00021.2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
68 Best J, Zahn A, Beilfuß A, Sydor S, Fingas C, Sowa J, Anastasiou O, Cicinnati V, Gerken G, Canbay A, Bechmann LP. Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCV. Annals of Hepatology 2015;14:396-403. [DOI: 10.1016/s1665-2681(19)31280-3] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
69 Kumar V, Mahato RI. Delivery and targeting of miRNAs for treating liver fibrosis. Pharm Res 2015;32:341-61. [PMID: 25186440 DOI: 10.1007/s11095-014-1497-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
70 Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 1-87. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Fan X, Lin L, Cui B, Zhao T, Mao L, Song Y, Wang X, Feng H, Qingxiang Y, Zhang J, Jiang K, Cao X, Wang B, Sun C. Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe. Pharmacol Res 2020;159:104945. [PMID: 32454225 DOI: 10.1016/j.phrs.2020.104945] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
72 Cazanave SC, Sanyal AJ. Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease. In: Ntambi JM, editor. Hepatic De Novo Lipogenesis and Regulation of Metabolism. Cham: Springer International Publishing; 2016. pp. 101-29. [DOI: 10.1007/978-3-319-25065-6_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, Carreras MC, Poderoso JJ, Gores GJ. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int. 2015;35:953-966. [PMID: 24750664 DOI: 10.1111/liv.12570] [Cited by in Crossref: 164] [Cited by in F6Publishing: 157] [Article Influence: 23.4] [Reference Citation Analysis]
74 Zhu Y, Xiao X, Li G, Bu J, Zhou W, Zhou S. Isoflurane anesthesia induces liver injury by regulating the expression of insulin-like growth factor 1. Exp Ther Med 2017;13:1608-13. [PMID: 28413517 DOI: 10.3892/etm.2017.4157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
75 Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2016;8:166-178. [PMID: 27698966 DOI: 10.15171/mejdd.2016.29] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
76 Liu C, Tao Q, Sun M, Wu JZ, Yang W, Jian P, Peng J, Hu Y, Liu C, Liu P. Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest. 2010;90:1805-1816. [PMID: 20921949 DOI: 10.1038/labinvest.2010.123] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 7.8] [Reference Citation Analysis]
77 Minigalieva IA, Katsnelson BA, Privalova LI, Sutunkova MP, Gurvich VB, Shur VY, Shishkina EV, Valamina IE, Makeyev OH, Panov VG, Varaksin AN, Bushueva TV, Sakhautdinova RR, Klinova SV, Solovyeva SN, Meshtcheryakova EY. Combined Subchronic Toxicity of Aluminum (III), Titanium (IV) and Silicon (IV) Oxide Nanoparticles and Its Alleviation with a Complex of Bioprotectors. Int J Mol Sci 2018;19:E837. [PMID: 29534019 DOI: 10.3390/ijms19030837] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
78 Yang Q, Shi Y, He J, Chen Z. The evolving story of macrophages in acute liver failure. Immunol Lett. 2012;147:1-9. [PMID: 22820147 DOI: 10.1016/j.imlet.2012.07.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
79 Lee TF, Lin YL, Huang YT. Protective effects of kaerophyllin against liver fibrogenesis in rats. Eur J Clin Invest. 2012;42:607-616. [PMID: 22103576 DOI: 10.1111/j.1365-2362.2011.02625.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
80 Rada P, González-Rodríguez Á, García-Monzón C, Valverde ÁM. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis 2020;11:802. [PMID: 32978374 DOI: 10.1038/s41419-020-03003-w] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
81 Shih SC, Ho TC, Chen SL, Tsao YP. Pigment Epithelium Derived Factor Peptide Protects Murine Hepatocytes from Carbon Tetrachloride-Induced Injury. PLoS One 2016;11:e0157647. [PMID: 27384427 DOI: 10.1371/journal.pone.0157647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
82 Njoku DB, Talor MV, Fairweather D, Frisancho-Kiss S, Odumade OA, Rose NR. A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse. Exp Mol Pathol 2005;78:87-100. [PMID: 15713433 DOI: 10.1016/j.yexmp.2004.10.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
83 Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61:1066-1079. [PMID: 25066777 DOI: 10.1002/hep.27332] [Cited by in Crossref: 419] [Cited by in F6Publishing: 422] [Article Influence: 69.8] [Reference Citation Analysis]
84 Korolenko TA, Klishevich MS, Cherkanova MS, Alexeenko TV, Zhanaeva SY, Savchenko NG, Goncharova IA, Filjushina EE. In vivo effect of selective macrophage suppression on the development of intrahepatic cholestasis in mice. Bull Exp Biol Med 2008;146:396-400. [PMID: 19489305 DOI: 10.1007/s10517-009-0312-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Elpek G&. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014; 20(23): 7260-7276 [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 156] [Article Influence: 24.7] [Reference Citation Analysis]
86 Han JH, Kim OH, Lee SC, Kim KH, Park JH, Lee JI, Lee KH, Hong HE, Seo H, Choi HJ, Ju JH, Kim SJ. A Novel Hepatic Anti-Fibrotic Strategy Utilizing the Secretome Released from Etanercept-Synthesizing Adipose-Derived Stem Cells. Int J Mol Sci 2019;20:E6302. [PMID: 31847135 DOI: 10.3390/ijms20246302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
87 Böttinger EP. TGF-beta in renal injury and disease. Semin Nephrol. 2007;27:309-320. [PMID: 17533008 DOI: 10.1016/j.semnephrol.2007.02.009] [Cited by in Crossref: 243] [Cited by in F6Publishing: 246] [Article Influence: 17.4] [Reference Citation Analysis]
88 Gandhi CR. Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver. Front Med (Lausanne) 2020;7:130. [PMID: 32373617 DOI: 10.3389/fmed.2020.00130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
89 Marquès JM, Belza I, Holtmann B, Pennica D, Prieto J, Bustos M. Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology 2007;45:639-48. [PMID: 17326158 DOI: 10.1002/hep.21508] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
90 Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology. 2011;53:306-316. [PMID: 21140375 DOI: 10.1002/hep.24029] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
91 Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology. 2006;43:335-344. [PMID: 16440346 DOI: 10.1002/hep.21036] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 6.0] [Reference Citation Analysis]
92 Menzel O, Birraux J, Wildhaber BE, Jond C, Lasne F, Habre W, Trono D, Nguyen TH, Chardot C. Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. Mol Ther 2009;17:1754-60. [PMID: 19568222 DOI: 10.1038/mt.2009.143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
93 Piao X, Komazawa-Sakon S, Nishina T, Koike M, Piao JH, Ehlken H, Kurihara H, Hara M, Van Rooijen N, Schütz G, Ohmuraya M, Uchiyama Y, Yagita H, Okumura K, He YW, Nakano H. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci Signal 2012;5:ra93. [PMID: 23250397 DOI: 10.1126/scisignal.2003558] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
94 Soliman HM, Selim AO. Role of hepatic stellate cells in fibrogenesis in a model of pomegranate-treated fatty liver induced by junk food in male albino rats immunohistochemical and electron microscopic study: . The Egyptian Journal of Histology 2012;35:54-66. [DOI: 10.1097/01.ehx.0000410947.56955.e0] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
95 Lee YJ, Hsu JD, Lin WL, Kao SH, Wang CJ. Upregulation of caveolin-1 by mulberry leaf extract and its major components, chlorogenic acid derivatives, attenuates alcoholic steatohepatitis via inhibition of oxidative stress. Food Funct 2017;8:397-405. [PMID: 28074952 DOI: 10.1039/c6fo01539e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
96 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1628] [Article Influence: 129.4] [Reference Citation Analysis]
97 邵祥强, 肖华胜. 肝纤维化发病机制与临床诊断的研究进展. 世界华人消化杂志 2011; 19(3): 268-274 [DOI: 10.11569/wcjd.v19.i3.268] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
98 Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15:349-364. [PMID: 29740166 DOI: 10.1038/s41575-018-0009-6] [Cited by in Crossref: 197] [Cited by in F6Publishing: 196] [Article Influence: 98.5] [Reference Citation Analysis]
99 Chakraborty JB, Oakley F, Walsh MJ. Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. Int J Hepatol. 2012;2012:648915. [PMID: 22567408 DOI: 10.1155/2012/648915] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 7.3] [Reference Citation Analysis]
100 Zhang L, Bansal MB. Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection. Front Immunol 2020;11:1086. [PMID: 32612603 DOI: 10.3389/fimmu.2020.01086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Cordero-Espinoza L, Huch M. The balancing act of the liver: tissue regeneration versus fibrosis. J Clin Invest 2018;128:85-96. [PMID: 29293095 DOI: 10.1172/JCI93562] [Cited by in Crossref: 77] [Cited by in F6Publishing: 50] [Article Influence: 25.7] [Reference Citation Analysis]
102 Maliken BD, Nelson JE, Klintworth HM, Beauchamp M, Yeh MM, Kowdley KV. Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease. Hepatology. 2013;57:1806-1813. [PMID: 23325576 DOI: 10.1002/hep.26238] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
103 Shen X, Peng Y, Li H. The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis. Front Immunol 2017;8:1450. [PMID: 29163520 DOI: 10.3389/fimmu.2017.01450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
104 Feld JJ, Liang TJ. Hepatitis C — identifying patients with progressive liver injury. Hepatology 2006;43:S194-206. [DOI: 10.1002/hep.21065] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
105 Tu Y, Chen D, Pan T, Chen Z, Xu J, Jin L, Sheng L, Jin X, Wang X, Lan X, Ge Y, Sun H, Chen Y. Inhibition of miR-431-5p attenuated liver apoptosis through KLF15/p53 signal pathway in S100 induced autoimmune hepatitis mice. Life Sci 2021;280:119698. [PMID: 34111466 DOI: 10.1016/j.lfs.2021.119698] [Reference Citation Analysis]
106 Liu Q, Wang CY, Liu Z, Ma XS, He YH, Chen SS, Bai XY. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling. Pharm Biol. 2014;52:1085-1093. [PMID: 24618007 DOI: 10.3109/13880209.2013.877491] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
107 Lacoste B, Raymond VA, Lapierre P, Bilodeau M. Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes. PLoS One. 2016;11:e0165360. [PMID: 27792745 DOI: 10.1371/journal.pone.0165360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
108 李鹏, 李昌平. 细胞凋亡在非酒精性脂肪性肝病中的作用. 世界华人消化杂志 2008; 16(20): 2253-2258 [DOI: 10.11569/wcjd.v16.i20.2253] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
109 Tiao MM, Huang LT, Chen CJ, Sheen JM, Tain YL, Chen CC, Kuo HC, Huang YH, Tang KS, Chu EW, Yu HR. Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure. Biomed Res Int 2014;2014:942172. [PMID: 24822223 DOI: 10.1155/2014/942172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
110 Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1083-G1088. [PMID: 16687579 DOI: 10.1152/ajpgi.00568.2005] [Cited by in Crossref: 307] [Cited by in F6Publishing: 305] [Article Influence: 20.5] [Reference Citation Analysis]
111 Osawa Y, Seki E, Adachi M, Suetsugu A, Ito H, Moriwaki H, Seishima M, Nagaki M. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice. Hepatology. 2010;51:237-245. [PMID: 19821528 DOI: 10.1002/hep.23262] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
112 Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803-816. [PMID: 19090740 DOI: 10.1586/17474124.2.6.803] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
113 Vekemans K, Braet F. Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. World J Gastroenterol 2005; 11(33): 5095-5102 [PMID: 16127736 DOI: 10.3748/wjg.v11.i33.5095] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
114 Wang K, Brems JJ, Gamelli RL, Holterman A. Foxa2 may modulate hepatic apoptosis through the cIAP1 pathway. Cellular Signalling 2013;25:867-74. [DOI: 10.1016/j.cellsig.2012.12.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
115 Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. 2016;17:29-39. [PMID: 26847547 DOI: 10.1007/s11154-016-9339-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
116 Hirsova P, Ibrahim SH, Malhi H, Gores GJ. Hepatocyte Lethal and Nonlethal Lipotoxic Injury. In: Ding W, Yin X, editors. Cellular Injury in Liver Diseases. Cham: Springer International Publishing; 2017. pp. 105-17. [DOI: 10.1007/978-3-319-53774-0_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther. 2004;308:1191-1196. [PMID: 14617689 DOI: 10.1124/jpet.103.060129] [Cited by in Crossref: 158] [Cited by in F6Publishing: 146] [Article Influence: 8.8] [Reference Citation Analysis]
118 Du Y, Li N, Long M. Liver sinusoid on a chip. Methods Cell Biol 2018;146:105-34. [PMID: 30037457 DOI: 10.1016/bs.mcb.2018.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
119 Toriguchi K, Hatano E, Tanabe K, Takemoto K, Nakamura K, Koyama Y, Seo S, Taura K, Uemoto S. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency. J Gastroenterol Hepatol. 2014;29:1109-1118. [PMID: 24329600 DOI: 10.1111/jgh.12481] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
120 Yueh MF, Taniguchi K, Chen S, Evans RM, Hammock BD, Karin M, Tukey RH. The commonly used antimicrobial additive triclosan is a liver tumor promoter. Proc Natl Acad Sci U S A 2014;111:17200-5. [PMID: 25404284 DOI: 10.1073/pnas.1419119111] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 18.1] [Reference Citation Analysis]
121 Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut. 2005;54:1024-1033. [PMID: 15951554 DOI: 10.1136/gut.2004.053850] [Cited by in Crossref: 307] [Cited by in F6Publishing: 312] [Article Influence: 19.2] [Reference Citation Analysis]
122 Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, Crispe IN, Topham DJ, Pierce RH. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol. 2006;168:1169-1178; quiz 1404-1405. [PMID: 16565492 DOI: 10.2353/ajpath.2006.050875] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 6.1] [Reference Citation Analysis]
123 Iida A, Yoshidome H, Shida T, Kimura F, Shimizu H, Ohtsuka M, Morita Y, Takeuchi D, Miyazaki M. Does prolonged biliary obstructive jaundice sensitize the liver to endotoxemia? Shock. 2009;31:397-403. [PMID: 18665046 DOI: 10.1097/shk.0b013e31818349ea] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
124 Lee KC, Chan CC, Yang YY, Hsieh YC, Huang YH, Lin HC. Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice. Eur J Clin Invest. 2012;42:1261-1271. [PMID: 22998019 DOI: 10.1111/j.1365-2362.2012.02725.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
125 Song Z, Joshi-Barve S, Barve S, McClain CJ. Advances in alcoholic liver disease. Curr Gastroenterol Rep 2004;6:71-6. [PMID: 14720457 DOI: 10.1007/s11894-004-0029-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
126 Jiang JX, Török NJ. Liver Injury and the Activation of the Hepatic Myofibroblasts. Curr Pathobiol Rep. 2013;1:215-223. [PMID: 23977452 DOI: 10.1007/s40139-013-0019-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
127 Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 2004;11 Suppl 1:S37-S44. [PMID: 15243580 DOI: 10.1038/sj.cdd.4401450] [Cited by in Crossref: 227] [Cited by in F6Publishing: 216] [Article Influence: 14.2] [Reference Citation Analysis]
128 Nesset CK, Kong XY, Damme M, Schjalm C, Roos N, Løberg EM, Eskild W. Age-dependent development of liver fibrosis in Glmp (gt/gt) mice. Fibrogenesis Tissue Repair 2016;9:5. [PMID: 27141234 DOI: 10.1186/s13069-016-0042-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
129 Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol 2021;27:413-24. [PMID: 33317250 DOI: 10.3350/cmh.2020.0187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol 2010; 1(2): 69-84 [PMID: 21607144 DOI: 10.4291/wjgp.v1.i2.69] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
131 Kumagai K, Ito K, Ando Y, Hakamata S, Teranishi M, Nakayama H, Manabe S. Neutralization of IL-10 Exacerbates Cycloheximide-Induced Hepatocellular Apoptosis and Necrosis. Toxicol Pathol 2009;37:536-46. [DOI: 10.1177/0192623309336153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
132 Bayomy NA, Soliman GM, Abdelaziz EZ. Effect of Potassium Bromate on the Liver of Adult Male Albino Rat and A Possible Protective Role of Vitamin C: Histological, Immunohistochemical, and Biochemical Study. Anat Rec (Hoboken) 2016;299:1256-69. [PMID: 27373450 DOI: 10.1002/ar.23386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
133 Mekala S, Tulimilli SV, Geesala R, Manupati K, Dhoke NR, Das A. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells. Can J Physiol Pharmacol 2018;96:728-41. [DOI: 10.1139/cjpp-2017-0768] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
134 Koyama Y, Taura K, Hatano E, Tanabe K, Yamamoto G, Nakamura K, Yamanaka K, Kitamura K, Narita M, Nagata H. Effects of oral intake of hydrogen water on liver fibrogenesis in mice. Hepatol Res. 2014;44:663-677. [PMID: 23682614 DOI: 10.1111/hepr.12165] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
135 Janel N, Noll C. Protection and Reversal of Hepatic Fibrosis by Polyphenols. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 665-79. [DOI: 10.1016/b978-0-12-398456-2.00051-7] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
136 Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005;10:927-939. [PMID: 16151628 DOI: 10.1007/s10495-005-1055-4] [Cited by in Crossref: 294] [Cited by in F6Publishing: 288] [Article Influence: 19.6] [Reference Citation Analysis]
137 Park SM. The crucial role of cholangiocytes in cholangiopathies. Gut Liver. 2012;6:295-304. [PMID: 22844556 DOI: 10.5009/gnl.2012.6.3.295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
138 Liu W, Ye C, Cheng Q, Zhang X, Yao L, Li Q, Huang J, Liu Y, Zou Z, Wang H, Yan J, Zhu Y, Wang C, Ai D. Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol 2019;7:211-31. [PMID: 30539788 DOI: 10.1016/j.jcmgh.2018.09.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
139 Kinchen JM. A model to die for: signaling to apoptotic cell removal in worm, fly and mouse. Apoptosis 2010;15:998-1006. [PMID: 20461556 DOI: 10.1007/s10495-010-0509-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
140 Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, Charlton MR, Shah VH, Malhi H, Gores GJ. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. Gastroenterology. 2016;150:956-967. [PMID: 26764184 DOI: 10.1053/j.gastro.2015.12.037] [Cited by in Crossref: 203] [Cited by in F6Publishing: 205] [Article Influence: 40.6] [Reference Citation Analysis]
141 Guicciardi ME, Gores GJ. Cholestatic hepatocellular injury: what do we know and how should we proceed. Journal of Hepatology 2005;42:297-300. [DOI: 10.1016/j.jhep.2004.12.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
142 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
143 Walenbergh SM, Koek GH, Bieghs V, Shiri-Sverdlov R. Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. J Hepatol. 2013;58:801-810. [PMID: 23183522 DOI: 10.1016/j.jhep.2012.11.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
144 Best J, Verhulst S, Syn WK, Lagaisse K, van Hul N, Heindryckx F, Sowa JP, Peeters L, Van Vlierberghe H, Leclercq IA, Canbay A, Dollé L, van Grunsven LA. Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies. PLoS One 2016;11:e0162286. [PMID: 27618307 DOI: 10.1371/journal.pone.0162286] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
145 Balasubramanian S, Kowdley KV. Effect of Alcohol on Viral Hepatitis and Other Forms of Liver Dysfunction. Clinics in Liver Disease 2005;9:83-101. [DOI: 10.1016/j.cld.2004.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
146 Friedman SL. Hepatic fibrosis-overview. Toxicology. 2008;254:120-129. [PMID: 18662740 DOI: 10.1016/j.tox.2008.06.013] [Cited by in Crossref: 240] [Cited by in F6Publishing: 227] [Article Influence: 18.5] [Reference Citation Analysis]
147 Lee KC, Chan CC, Yang YY, Hsieh YC, Huang YH, Lin HC. Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet. PLoS One 2013;8:e77817. [PMID: 24204981 DOI: 10.1371/journal.pone.0077817] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
148 Zwicker C, Bujko A, Scott CL. Hepatic Macrophage Responses in Inflammation, a Function of Plasticity, Heterogeneity or Both? Front Immunol 2021;12:690813. [PMID: 34177948 DOI: 10.3389/fimmu.2021.690813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76:99-128. [PMID: 30343320 DOI: 10.1007/s00018-018-2947-0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 118] [Article Influence: 36.3] [Reference Citation Analysis]
150 Dalton SR, Lee SM, King RN, Nanji AA, Kharbanda KK, Casey CA, McVicker BL. Carbon tetrachloride-induced liver damage in asialoglycoprotein receptor-deficient mice. Biochem Pharmacol 2009;77:1283-90. [PMID: 19185565 DOI: 10.1016/j.bcp.2008.12.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
151 Zandieh A, Payabvash S, Pasalar P, Morteza A, Zandieh B, Tavangar SM, Dehpour AR. Gadolinium chloride, a Kupffer cell inhibitor, attenuates hepatic injury in a rat model of chronic cholestasis. Hum Exp Toxicol 2011;30:1804-10. [PMID: 21339256 DOI: 10.1177/0960327111400106] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
152 Wang Y, Seitz HK, Wang XD. Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcohol Clin Exp Res. 2010;34:567-573. [PMID: 20028348 DOI: 10.1111/j.1530-0277.2009.01122.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
153 Kong XY, Nesset CK, Damme M, Løberg EM, Lübke T, Mæhlen J, Andersson KB, Lorenzo PI, Roos N, Thoresen GH, Rustan AC, Kase ET, Eskild W. Loss of lysosomal membrane protein NCU-G1 in mice results in spontaneous liver fibrosis with accumulation of lipofuscin and iron in Kupffer cells. Dis Model Mech 2014;7:351-62. [PMID: 24487409 DOI: 10.1242/dmm.014050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
154 Petrasek J, Mandrekar P, Szabo G. Toll-like receptors in the pathogenesis of alcoholic liver disease. Gastroenterol Res Pract. 2010;2010:710381. [PMID: 20827314 DOI: 10.1155/2010/710381] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
155 Leone V, Ali A, Weber A, Tschaharganeh DF, Heikenwalder M. Liver Inflammation and Hepatobiliary Cancers. Trends Cancer 2021;7:606-23. [PMID: 33674229 DOI: 10.1016/j.trecan.2021.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Matsubara T, Tanaka N, Patterson AD, Cho JY, Krausz KW, Gonzalez FJ. Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology 2011;53:1282-93. [PMID: 21480330 DOI: 10.1002/hep.24193] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
157 Mazaheri N, Naghsh N, Karimi A, Salavati H. In vivo Toxicity Investigation of Magnesium Oxide Nanoparticles in Rat for Environmental and Biomedical Applications. Iran J Biotechnol 2019;17:e1543. [PMID: 31457037 DOI: 10.21859/ijb.1543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
158 Gonçalves IO, Oliveira PJ, Ascensão A, Magalhães J. Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. Eur J Clin Invest 2013;43:1184-94. [PMID: 24033085 DOI: 10.1111/eci.12146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
159 Roy DN, Sen G, Chowdhury KD, Biswas T. Combination therapy with andrographolide and d-penicillamine enhanced therapeutic advantage over monotherapy with d-penicillamine in attenuating fibrogenic response and cell death in the periportal zone of liver in rats during copper toxicosis. Toxicol Appl Pharmacol 2011;250:54-68. [PMID: 20946909 DOI: 10.1016/j.taap.2010.09.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
160 Kudo H, Takahara T, Yata Y, Kawai K, Zhang W, Sugiyama T. Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J Hepatol. 2009;51:168-175. [PMID: 19446916 DOI: 10.1016/j.jhep.2009.02.032] [Cited by in Crossref: 107] [Cited by in F6Publishing: 113] [Article Influence: 8.9] [Reference Citation Analysis]
161 Kogianni G, Mann V, Noble BS. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res 2008;23:915-27. [PMID: 18435576 DOI: 10.1359/jbmr.080207] [Cited by in Crossref: 147] [Cited by in F6Publishing: 122] [Article Influence: 11.3] [Reference Citation Analysis]
162 Dabbagh A, Rajaei S. The role of anesthetic drugs in liver apoptosis. Hepat Mon 2013;13:e13162. [PMID: 24069040 DOI: 10.5812/hepatmon.13162] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
163 Diesen DL, Kuo PC. Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. J Surg Res. 2010;162:95-109. [PMID: 20444470 DOI: 10.1016/j.jss.2009.09.019] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
164 Krysko DV, Vandenabeele P. From regulation of dying cell engulfment to development of anti-cancer therapy. Cell Death Differ 2008;15:29-38. [DOI: 10.1038/sj.cdd.4402271] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
165 Rajapaksha IG, Mak KY, Huang P, Burrell LM, Angus PW, Herath CB. The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice. Sci Rep 2018;8:10175. [PMID: 29977014 DOI: 10.1038/s41598-018-28490-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
166 Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol. 2013;3:977-1010. [PMID: 23720337 DOI: 10.1002/cphy.c120020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 103] [Article Influence: 6.3] [Reference Citation Analysis]
167 Li-ping G, Ren-hua L, Yan-jie L. Serine proteinase (SP) and serine protease inhibitor (serpin) gene expression after hormone treatment in the silkworm Bombyx mori (Lepidoptera: Bombycidae). Journal of Asia-Pacific Entomology 2016;19:1203-10. [DOI: 10.1016/j.aspen.2016.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
168 Alisi A, Carpino G, Oliveira FL, Panera N, Nobili V, Gaudio E. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. Mediators Inflamm. 2017;2017:8162421. [PMID: 28115795 DOI: 10.1155/2017/8162421] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 18.0] [Reference Citation Analysis]
169 谢汝佳, 韩冰, 杨婷, 杨勤. 内质网应激凋亡通路中Caspase12激活介导的肝纤维化大鼠肝细胞凋亡. 世界华人消化杂志 2016; 24(16): 2470-2477 [DOI: 10.11569/wcjd.v24.i16.2470] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
170 Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One. 2013;8:e70599. [PMID: 23894677 DOI: 10.1371/journal.pone.0070599] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 8.1] [Reference Citation Analysis]
171 Sigal M, Siebert N, Zechner D, Menschikow E, Abshagen K, Vollmar B, Eipel C. Darbepoetin-α inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice. Lab Invest 2010;90:1447-56. [PMID: 20567234 DOI: 10.1038/labinvest.2010.115] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
172 Woolbright BL, Jaeschke H. The impact of sterile inflammation in acute liver injury. J Clin Transl Res. 2017;3:170-188. [PMID: 28670626 DOI: 10.18053/jctres.03.2017s1.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
173 Vidali M, Stewart SF, Albano E. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol Med. 2008;14:63-71. [PMID: 18222109 DOI: 10.1016/j.molmed.2007.12.005] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
174 Wang H, Mehal W, Nagy LE, Rotman Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol Immunol 2021;18:73-91. [PMID: 33268887 DOI: 10.1038/s41423-020-00579-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
175 Katsnelson BA, Minigaliyeva IA, Panov VG, Privalova LI, Varaksin AN, Gurvich VB, Sutunkova MP, Shur VY, Shishkina EV, Valamina IE, Makeyev OH. Some patterns of metallic nanoparticles' combined subchronic toxicity as exemplified by a combination of nickel and manganese oxide nanoparticles. Food Chem Toxicol 2015;86:351-64. [PMID: 26607108 DOI: 10.1016/j.fct.2015.11.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
176 Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci 2014;15:9184-208. [PMID: 24865485 DOI: 10.3390/ijms15069184] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
177 Montano-Loza AJ, Thandassery RB, Czaja AJ. Targeting Hepatic Fibrosis in Autoimmune Hepatitis. Dig Dis Sci. 2016;61:3118-3139. [PMID: 27435327 DOI: 10.1007/s10620-016-4254-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
178 Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc. 2006;65:278-290. [PMID: 16923312 DOI: 10.1079/pns2006496] [Cited by in Crossref: 341] [Cited by in F6Publishing: 127] [Article Influence: 24.4] [Reference Citation Analysis]
179 Gieseler RK, Marquitan G, Schlattjan M, Sowa JP, Bechmann LP, Timm J, Roggendorf M, Gerken G, Friedman SL, Canbay A. Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C. J Viral Hepat 2011;18:760-7. [PMID: 20723040 DOI: 10.1111/j.1365-2893.2010.01362.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
180 Hathout L, Huang J, Zamani A, Morioka C, El-Saden S. White matter changes in chronic alcoholic liver disease: Hypothesized association and putative biochemical mechanisms. Med Hypotheses 2015;85:825-34. [PMID: 26474927 DOI: 10.1016/j.mehy.2015.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
181 Fujii H, Kawada N. Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol. 2012;47:215-225. [PMID: 22310735 DOI: 10.1007/s00535-012-0527-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 11.0] [Reference Citation Analysis]
182 Vuppalanchi R, Jain AK, Deppe R, Yates K, Comerford M, Masuoka HC, Neuschwander-Tetri BA, Loomba R, Brunt EM, Kleiner DE, Molleston JP, Schwimmer JB, Lavine JE, Tonascia J, Chalasani N. Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2014;12:2121-30.e1-2. [PMID: 24846279 DOI: 10.1016/j.cgh.2014.05.010] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 9.3] [Reference Citation Analysis]
183 Hatori A, Yui J, Xie L, Yamasaki T, Kumata K, Fujinaga M, Wakizaka H, Ogawa M, Nengaki N, Kawamura K, Zhang MR. Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa). PLoS One 2014;9:e86625. [PMID: 24466178 DOI: 10.1371/journal.pone.0086625] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
184 Mcclain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent Advances in Alcoholic Liver Disease IV. Dysregulated cytokine metabolism in alcoholic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2004;287:G497-502. [DOI: 10.1152/ajpgi.00171.2004] [Cited by in Crossref: 165] [Cited by in F6Publishing: 158] [Article Influence: 9.7] [Reference Citation Analysis]
185 Ye Z, Houssein HS, Mahato RI. Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides 2007;17:349-404. [PMID: 18154454 DOI: 10.1089/oli.2007.0097] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
186 Li X, Wu Z, Ni J, Liu Y, Meng J, Yu W, Nakanishi H, Zhou Y. Cathepsin B Regulates Collagen Expression by Fibroblasts via Prolonging TLR2/NF-κB Activation. Oxid Med Cell Longev 2016;2016:7894247. [PMID: 27648120 DOI: 10.1155/2016/7894247] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
187 Wang M, Yu F, Li P, Wang K. Emerging Function and Clinical Significance of Exosomal circRNAs in Cancer. Mol Ther Nucleic Acids 2020;21:367-83. [PMID: 32650235 DOI: 10.1016/j.omtn.2020.06.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
188 Farghali H, Kemelo MK, Canová NK. SIRT1 Modulators in Experimentally Induced Liver Injury. Oxid Med Cell Longev 2019;2019:8765954. [PMID: 31281594 DOI: 10.1155/2019/8765954] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
189 Al-humadi H, Zarros A, Kyriakaki A, Al-saigh R, Liapi C. Choline deprivation: An overview of the major hepatic metabolic response pathways. Scandinavian Journal of Gastroenterology 2012;47:874-86. [DOI: 10.3109/00365521.2012.685755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
190 Crawford JM, Burt AD. Anatomy, pathophysiology and basic mechanisms of disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 1-77. [DOI: 10.1016/b978-0-7020-3398-8.00001-5] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
191 Azam F, Sheikh N, Ali G, Tayyeb A. Fagonia indica Repairs Hepatic Damage through Expression Regulation of Toll-Like Receptors in a Liver Injury Model. J Immunol Res 2018;2018:7967135. [PMID: 30057922 DOI: 10.1155/2018/7967135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
192 Kurosawa T, Goto M, Kaji N, Aikiyo S, Mihara T, Ikemoto-Uezumi M, Toyoda M, Kanazawa N, Nakazawa T, Hori M, Uezumi A. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα. Cell Death Dis 2021;12:11. [PMID: 33414474 DOI: 10.1038/s41419-020-03353-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T, Iwaisako K, Seo S, Nakajima A, Ikai I. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Am J Physiol Gastrointest Liver Physiol. 2008;294:G498-G505. [PMID: 18174271 DOI: 10.1152/ajpgi.00482.2007] [Cited by in Crossref: 140] [Cited by in F6Publishing: 146] [Article Influence: 10.8] [Reference Citation Analysis]
194 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 49.0] [Reference Citation Analysis]
195 Lam HYP, Liang TR, Peng SY. Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo. PLoS Negl Trop Dis 2021;15:e0009554. [PMID: 34161342 DOI: 10.1371/journal.pntd.0009554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Kahraman A, Mott JL, Bronk SF, Werneburg NW, Barreyro FJ, Guicciardi ME, Akazawa Y, Braley K, Craig RW, Gores GJ. Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse. Dig Dis Sci. 2009;54:1908-1917. [PMID: 19051025 DOI: 10.1007/s10620-008-0583-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
197 Suh YG, Jeong WI. Hepatic stellate cells and innate immunity in alcoholic liver disease. World J Gastroenterol 2011; 17(20): 2543-2551 [PMID: 21633659 DOI: 10.3748/wjg.v17.i20.2543] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
198 Davis GL, Krawczynski K, Szabo G. Hepatitis C Virus Infection—Pathobiology and Implications for New Therapeutic Options. Dig Dis Sci 2007;52:857-75. [DOI: 10.1007/s10620-006-9484-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
199 Balistreri WF, Bezerra JA, Jansen P, Karpen SJ, Shneider BL, Suchy FJ. Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology. 2005;42:222-235. [PMID: 15898074 DOI: 10.1002/hep.20729] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
200 Itoh M, Suganami T, Kato H, Kanai S, Shirakawa I, Sakai T, Goto T, Asakawa M, Hidaka I, Sakugawa H, Ohnishi K, Komohara Y, Asano K, Sakaida I, Tanaka M, Ogawa Y. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis. JCI Insight 2017;2:92902. [PMID: 29202448 DOI: 10.1172/jci.insight.92902] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
201 Simón J, Delgado TC, Martinez-Cruz LA, Martínez-Chantar ML. Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities. Biomedicines 2021;9:125. [PMID: 33513920 DOI: 10.3390/biomedicines9020125] [Reference Citation Analysis]
202 Garcia-Tsao G, Fuchs M, Shiffman M, Borg BB, Pyrsopoulos N, Shetty K, Gallegos-Orozco JF, Reddy KR, Feyssa E, Chan JL, Yamashita M, Robinson JM, Spada AP, Hagerty DT, Bosch J. Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension. Hepatology 2019;69:717-28. [PMID: 30063802 DOI: 10.1002/hep.30199] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
203 Seo W, Jeong WI. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease? World J Gastroenterol 2016; 22(4): 1348-1356 [PMID: 26819504 DOI: 10.3748/wjg.v22.i4.1348] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
204 Marrone G, Shah VH, Gracia-Sancho J. Sinusoidal communication in liver fibrosis and regeneration. J Hepatol 2016;65:608-17. [PMID: 27151183 DOI: 10.1016/j.jhep.2016.04.018] [Cited by in Crossref: 120] [Cited by in F6Publishing: 115] [Article Influence: 24.0] [Reference Citation Analysis]
205 Huang L, Heinloth AN, Zeng ZB, Paules RS, Bushel PR. Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants. BMC Genomics 2008;9:288. [PMID: 18558008 DOI: 10.1186/1471-2164-9-288] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
206 Woolbright BL, McGill MR, Yan H, Jaeschke H. Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes. Basic Clin Pharmacol Toxicol. 2016;118:160-167. [PMID: 26176423 DOI: 10.1111/bcpt.12449] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
207 Yang YM, Seki E. TNFα in liver fibrosis. Curr Pathobiol Rep 2015;3:253-61. [PMID: 26726307 DOI: 10.1007/s40139-015-0093-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 9.7] [Reference Citation Analysis]
208 Ben Moshe T, Barash H, Kang TB, Kim JC, Kovalenko A, Gross E, Schuchmann M, Abramovitch R, Galun E, Wallach D. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 2007;45:1014-24. [PMID: 17385212 DOI: 10.1002/hep.21495] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
209 Popov Y, Sverdlov DY, Bhaskar KR, Sharma AK, Millonig G, Patsenker E, Krahenbuhl S, Krahenbuhl L, Schuppan D. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am J Physiol Gastrointest Liver Physiol. 2010;298:G323-G334. [PMID: 20056896 DOI: 10.1152/ajpgi.00394.2009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 8.1] [Reference Citation Analysis]
210 Zheng C, Sui B, Zhang X, Hu J, Chen J, Liu J, Wu D, Ye Q, Xiang L, Qiu X, Liu S, Deng Z, Zhou J, Liu S, Shi S, Jin Y. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes. J Extracell Vesicles 2021;10:e12109. [PMID: 34084287 DOI: 10.1002/jev2.12109] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
211 Kumar S, Wang J, Shanmukhappa SK, Gandhi CR. Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells. Am J Pathol. 2017;187:1356-1367. [PMID: 28412299 DOI: 10.1016/j.ajpath.2017.01.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
212 Liu X, Mi X, Wang Z, Zhang M, Hou J, Jiang S, Wang Y, Chen C, Li W. Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis 2020;11:454. [PMID: 32532964 DOI: 10.1038/s41419-020-2597-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
213 Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol 2012;12:201-13. [PMID: 22362353 DOI: 10.1038/nri3169] [Cited by in Crossref: 322] [Cited by in F6Publishing: 308] [Article Influence: 35.8] [Reference Citation Analysis]
214 Kazankov K, Jørgensen SMD, Thomsen KL, Møller HJ, Vilstrup H, George J, Schuppan D, Grønbæk H. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol 2019;16:145-59. [DOI: 10.1038/s41575-018-0082-x] [Cited by in Crossref: 177] [Cited by in F6Publishing: 189] [Article Influence: 59.0] [Reference Citation Analysis]
215 Shigekawa M, Takehara T, Kodama T, Hikita H, Shimizu S, Li W, Miyagi T, Hosui A, Tatsumi T, Ishida H. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice. Biochem Biophys Res Commun. 2011;406:614-620. [PMID: 21356197 DOI: 10.1016/j.bbrc.2011.02.105] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
216 Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW, McKim SE, Parsons C, Rippe RA, Wheeler MD. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1318-G1328. [PMID: 16439470 DOI: 10.1152/ajpgi.00405.2005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
217 Zhao QH, Zhang XS, Wu K, Zhang J, Xia TF, Chen J, Qin ZS, Pang LQ. Preparation of Zoledronate liposome and its impact on apoptosis of Kupffer cells in rat liver. Acta Cir Bras 2018;33:1052-60. [PMID: 30624510 DOI: 10.1590/s0102-865020180120000002] [Reference Citation Analysis]
218 Eipel C, Hirschmann M, Abshagen K, Menger MD, Vollmar B. Local interaction of apoptotic hepatocytes and Kupffer cells in a rat model of systemic endotoxemia. Hepatol Res. 2007;37:863-871. [PMID: 17573953 DOI: 10.1111/j.1872-034x.2007.00133.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Huang YH, Tiao MM, Huang LT, Chuang JH, Kuo KC, Yang YL, Wang FS. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4. PLoS One. 2015;10:e0136453. [PMID: 26305546 DOI: 10.1371/journal.pone.0136453] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
220 Gracia-sancho J, Marrone G, Fernández-iglesias A. Hepatic microcirculation and mechanisms of portal hypertension. Nat Rev Gastroenterol Hepatol 2019;16:221-34. [DOI: 10.1038/s41575-018-0097-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 18.0] [Reference Citation Analysis]
221 Ono M, Saibara T. Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature. J Gastroenterol 2006;41:725-32. [PMID: 16988759 DOI: 10.1007/s00535-006-1876-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
222 Abe M, Usuda K, Hayashi S, Ogawa I, Furukawa S, Igarashi M, Nakae D. Carcinogenic risk of copper gluconate evaluated by a rat medium-term liver carcinogenicity bioassay protocol. Arch Toxicol 2008;82:563-71. [DOI: 10.1007/s00204-008-0294-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
223 Ai Y, Shi W, Zuo X, Sun X, Chen Y, Wang Z, Li R, Song X, Dai W, Mu W, Ding K, Li Z, Li Q, Xiao X, Zhan X, Bai Z. The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice. Front Pharmacol 2021;12:655531. [PMID: 34149411 DOI: 10.3389/fphar.2021.655531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
224 Ibrahim SH, Hirsova P, Gores GJ. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut. 2018;67:963-972. [PMID: 29367207 DOI: 10.1136/gutjnl-2017-315691] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 34.0] [Reference Citation Analysis]
225 Mou J, Wu S, Luo Z, Guo F, He H, Wang J, Lin F, Guo F, Sun J, Shen L, Zeng M, Wang C, Xu D, Gu Z, Tian X, Zhang A, Xu H, Yang L, Zhang X, Li J, Chen S. Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver disease. Bioorg Med Chem Lett 2018;28:1874-8. [PMID: 29650287 DOI: 10.1016/j.bmcl.2018.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
226 Mencin A, Seki E, Osawa Y, Kodama Y, De Minicis S, Knowles M, Brenner DA. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis. Hepatology. 2007;46:1443-1452. [PMID: 17668872 DOI: 10.1002/hep.21832] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
227 Wang Y, Li J, Wang X, Zhou Y, Zhang T, Ho W. HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes. Hepat Mon 2015;15:e29282. [PMID: 26322111 DOI: 10.5812/hepatmon.29282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
228 Lee YH, Son JY, Kim KS, Park YJ, Kim HR, Park JH, Kim KB, Lee KY, Kang KW, Kim IS, Kacew S, Lee BM, Kim HS. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats. Int J Mol Sci 2019;20:E3709. [PMID: 31362375 DOI: 10.3390/ijms20153709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
229 Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr. 2008;138:1866-1871. [PMID: 18806094 DOI: 10.1093/jn/138.10.1866] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 6.2] [Reference Citation Analysis]
230 Cubero FJ, Nieto N. Arachidonic acid stimulates TNFα production in Kupffer cells via a reactive oxygen species-pERK1/2-Egr1-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2012;303:G228-39. [PMID: 22538404 DOI: 10.1152/ajpgi.00465.2011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
231 Kälsch J, Bechmann LP, Kälsch H, Schlattjan M, Erhard J, Gerken G, Canbay A. Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients. J Nutr Metab 2011;2011:369168. [PMID: 21773018 DOI: 10.1155/2011/369168] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
232 Laso FJ, Pastor I, Orfao A. [Immune system and alcoholic liver disease]. Med Clin (Barc) 2005;125:263-9. [PMID: 16137488 DOI: 10.1157/13078101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
233 Kazankov K, Barrera F, Møller HJ, Rosso C, Bugianesi E, David E, Younes R, Esmaili S, Eslam M, McLeod D, Bibby BM, Vilstrup H, George J, Grønbaek H. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease. Liver Int 2016;36:1549-57. [PMID: 27102725 DOI: 10.1111/liv.13150] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 12.2] [Reference Citation Analysis]
234 Rachakonda V, Jadeja RN, Urrunaga NH, Shah N, Ahmad D, Cheng K, Twaddell WS, Raufman JP, Khurana S. M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice. Sci Rep 2015;5:14110. [PMID: 26374068 DOI: 10.1038/srep14110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
235 Wallace K, Cowie DE, Konstantinou DK, Hill SJ, Tjelle TE, Axon A, Koruth M, White SA, Carlsen H, Mann DA, Wright MC. The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol 2010;120:137-48. [PMID: 20416375 DOI: 10.1016/j.jsbmb.2010.04.012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
236 Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34:84-129. [PMID: 23238855 DOI: 10.1210/er.2012-1009] [Cited by in Crossref: 132] [Cited by in F6Publishing: 127] [Article Influence: 14.7] [Reference Citation Analysis]
237 Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004;39:273-278. [PMID: 14767974 DOI: 10.1002/hep.20051] [Cited by in Crossref: 364] [Cited by in F6Publishing: 347] [Article Influence: 21.4] [Reference Citation Analysis]
238 Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, Oo YH, Mi Z, Pereira TA, Zdanowicz M, Malladi P. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology. 2011;53:106-115. [PMID: 20967826 DOI: 10.1002/hep.23998] [Cited by in Crossref: 163] [Cited by in F6Publishing: 159] [Article Influence: 14.8] [Reference Citation Analysis]
239 Negroni A, Cucchiara S, Stronati L. Apoptosis, Necrosis, and Necroptosis in the Gut and Intestinal Homeostasis. Mediators Inflamm 2015;2015:250762. [PMID: 26483605 DOI: 10.1155/2015/250762] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 11.7] [Reference Citation Analysis]
240 Kim KH, Park KK. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are? World J Gastroenterol 2014; 20(40): 14696-14705 [PMID: 25356032 DOI: 10.3748/wjg.v20.i40.14696] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
241 Husain H, Ahmad R, Khan A, Inamuddin, Asiri AM. Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis. International Journal of Biological Macromolecules 2018;111:379-92. [DOI: 10.1016/j.ijbiomac.2017.12.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
242 Ryu B, Kim C, Oh H, Kim U, Kim J, Jung C, Lee B, Lee S, Chang S, Lee JM, Chung H, Park J. Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol 2018;38:259-73. [DOI: 10.1002/jat.3520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
243 Wang K. Molecular mechanisms of liver injury: apoptosis or necrosis. Exp Toxicol Pathol. 2014;66:351-356. [PMID: 24867271 DOI: 10.1016/j.etp.2014.04.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
244 Kimura K, Moriwaki H, Nagaki M, Saio M, Nakamoto Y, Naito M, Kuwata K, Chisari FV. Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease. Am J Pathol 2006;168:786-95. [PMID: 16507894 DOI: 10.2353/ajpath.2006.050314] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
245 Syn WK, Choi SS, Diehl AM. Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:565-80. [PMID: 19818305 DOI: 10.1016/j.cld.2009.07.003] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 6.4] [Reference Citation Analysis]
246 Stalnikowitz DK, Weissbrod AB. Liver fibrosis and inflammation. A review. Annals of Hepatology 2003;2:159-63. [DOI: 10.1016/s1665-2681(19)32127-1] [Cited by in Crossref: 98] [Article Influence: 5.4] [Reference Citation Analysis]
247 Allen K, Jaeschke H, Copple BL. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol. 2011;178:175-186. [PMID: 21224055 DOI: 10.1016/j.ajpath.2010.11.026] [Cited by in Crossref: 267] [Cited by in F6Publishing: 261] [Article Influence: 24.3] [Reference Citation Analysis]
248 Fujimoto J, Iimuro Y. Carbon Tetrachloride-Induced Hepatotoxicity*. Comprehensive Toxicology. Elsevier; 2010. pp. 437-55. [DOI: 10.1016/b978-0-08-046884-6.01018-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
249 Wright JH, Johnson MM, Shimizu-Albergine M, Bauer RL, Hayes BJ, Surapisitchat J, Hudkins KL, Riehle KJ, Johnson SC, Yeh MM, Bammler TK, Beyer RP, Gilbertson DG, Alpers CE, Fausto N, Campbell JS. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int J Cancer. 2014;134:778-788. [PMID: 23929039 DOI: 10.1002/ijc.28421] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
250 Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman Symposium. Hepatology 2006;43:872-8. [DOI: 10.1002/hep.21107] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 7.7] [Reference Citation Analysis]
251 Kimura K, Nagaki M, Takai S, Satake S, Moriwaki H. Pivotal role of nuclear factor ?B signaling in anti-CD40-induced liver injury in mice. Hepatology 2004;40:1180-9. [DOI: 10.1002/hep.20432] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
252 Lafdil F, Chobert M, Deveaux V, Zafrani E, Mavier P, Nakano T, Laperche Y, Brouillet A. Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice. Journal of Hepatology 2009;51:55-66. [DOI: 10.1016/j.jhep.2009.02.030] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
253 Hirsova P, Gores GJ. Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol 2015;1:17-27. [PMID: 25729762 DOI: 10.1016/j.jcmgh.2014.11.005] [Cited by in Crossref: 98] [Cited by in F6Publishing: 102] [Article Influence: 16.3] [Reference Citation Analysis]
254 McVicker BL, Tuma DJ, Kharbanda KK, Kubik JL, Casey CA. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcohol Clin Exp Res. 2007;31:122-129. [PMID: 17207110 DOI: 10.1111/j.1530-0277.2006.00270.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
255 Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta 2009;1792:1062-72. [PMID: 19699298 DOI: 10.1016/j.bbadis.2009.08.007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
256 Hutson CL, Carroll DS, Gallardo-Romero N, Drew C, Zaki SR, Nagy T, Hughes C, Olson VA, Sanders J, Patel N, Smith SK, Keckler MS, Karem K, Damon IK. Comparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a Serial Sacrifice Study Design. Biomed Res Int 2015;2015:965710. [PMID: 26380309 DOI: 10.1155/2015/965710] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
257 Zubiete-Franco I, Fernández-Tussy P, Barbier-Torres L, Simon J, Fernández-Ramos D, Lopitz-Otsoa F, Gutiérrez-de Juan V, de Davalillo SL, Duce AM, Iruzubieta P, Taibo D, Crespo J, Caballeria J, Villa E, Aurrekoetxea I, Aspichueta P, Varela-Rey M, Lu SC, Mato JM, Beraza N, Delgado TC, Martínez-Chantar ML. Deregulated neddylation in liver fibrosis. Hepatology 2017;65:694-709. [PMID: 28035772 DOI: 10.1002/hep.28933] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
258 Woolbright BL, Jaeschke H. Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids. Gene Expr 2019;19:215-28. [PMID: 31253204 DOI: 10.3727/105221619X15614873062730] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
259 Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G, Kolb A, Friess H, Schuppan D. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 2008;48:453-64. [PMID: 18221819 DOI: 10.1016/j.jhep.2007.11.021] [Cited by in Crossref: 120] [Cited by in F6Publishing: 121] [Article Influence: 9.2] [Reference Citation Analysis]
260 Ramalho RM, Cortez-Pinto H, Castro RE, Solá S, Costa A, Moura MC, Camilo ME, Rodrigues CM. Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis. Eur J Gastroenterol Hepatol. 2006;18:21-29. [PMID: 16357615 DOI: 10.1097/00042737-200601000-00005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
261 Ito K, Kiyosawa N, Kumagai K, Manabe S, Matsunuma N, Yamoto T. Molecular mechanism investigation of cycloheximide-induced hepatocyte apoptosis in rat livers by morphological and microarray analysis. Toxicology 2006;219:175-86. [DOI: 10.1016/j.tox.2005.11.017] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
262 Papackova Z, Palenickova E, Dankova H, Zdychova J, Skop V, Kazdova L, Cahova M. Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages. Nutr Metab (Lond) 2012;9:22. [PMID: 22439764 DOI: 10.1186/1743-7075-9-22] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
263 Shiha GE, Abu-elsaad NM, Zalata KR, Ibrahim TM. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight. Clin Exp Pharmacol Physiol 2014;41:788-97. [DOI: 10.1111/1440-1681.12286] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
264 Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014;147:765-783.e4. [PMID: 25046161 DOI: 10.1053/j.gastro.2014.07.018] [Cited by in Crossref: 365] [Cited by in F6Publishing: 350] [Article Influence: 52.1] [Reference Citation Analysis]
265 Rajapaksha IG, Angus PW, Herath CB. Current therapies and novel approaches for biliary diseases. World J Gastrointest Pathophysiol 2019; 10(1): 1-10 [PMID: 30622832 DOI: 10.4291/wjgp.v10.i1.1] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
266 Aziz-Seible RS, Lee SM, Kharbanda KK, McVicker BL, Casey CA. Ethanol feeding potentiates the pro-inflammatory response of Kupffer cells to cellular fibronectin. Alcohol Clin Exp Res 2011;35:717-25. [PMID: 21223308 DOI: 10.1111/j.1530-0277.2010.01389.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
267 Masuoka HC, Guicciardi ME, Gores GJ. Caspase inhibitors for the treatment of hepatitis C. Clin Liver Dis 2009;13:467-75. [PMID: 19628162 DOI: 10.1016/j.cld.2009.05.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
268 Ben Moshe T, Kang T, Kovalenko A, Barash H, Abramovitch R, Galun E, Wallach D. Cell-autonomous and non-cell-autonomous functions of caspase-8. Cytokine & Growth Factor Reviews 2008;19:209-17. [DOI: 10.1016/j.cytogfr.2008.04.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
269 Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem. 2009;284:5637-5644. [PMID: 19119140 DOI: 10.1074/jbc.m807616200] [Cited by in Crossref: 273] [Cited by in F6Publishing: 162] [Article Influence: 22.8] [Reference Citation Analysis]
270 Hösel M, Quasdorff M, Ringelhan M, Kashkar H, Debey-Pascher S, Sprinzl MF, Bockmann JH, Arzberger S, Webb D, von Olshausen G, Weber A, Schultze JL, Büning H, Heikenwalder M, Protzer U. Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication. Cell Mol Gastroenterol Hepatol 2017;4:339-63. [PMID: 28884137 DOI: 10.1016/j.jcmgh.2017.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
271 Ganesan M, Poluektova LY, Enweluzo C, Kharbanda KK, Osna NA. Hepatitis C Virus-Infected Apoptotic Hepatocytes Program Macrophages and Hepatic Stellate Cells for Liver Inflammation and Fibrosis Development: Role of Ethanol as a Second Hit. Biomolecules 2018;8:E113. [PMID: 30322122 DOI: 10.3390/biom8040113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
272 Guicciardi ME, Gores GJ. Apoptosis as a mechanism for liver disease progression. Semin Liver Dis. 2010;30:402-410. [PMID: 20960379 DOI: 10.1055/s-0030-1267540] [Cited by in Crossref: 105] [Cited by in F6Publishing: 109] [Article Influence: 9.5] [Reference Citation Analysis]
273 Piao X, Yamazaki S, Komazawa-Sakon S, Miyake S, Nakabayashi O, Kurosawa T, Mikami T, Tanaka M, Van Rooijen N, Ohmuraya M, Oikawa A, Kojima Y, Kakuta S, Uchiyama Y, Tanaka M, Nakano H. Depletion of myeloid cells exacerbates hepatitis and induces an aberrant increase in histone H3 in mouse serum. Hepatology 2017;65:237-52. [PMID: 27770461 DOI: 10.1002/hep.28878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
274 Gehrke N, Garcia-Bardon D, Mann A, Schad A, Alt Y, Wörns MA, Sprinzl MF, Zimmermann T, Menke J, Engstler AJ, Bergheim I, He YW, Galle PR, Schuchmann M, Schattenberg JM. Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors. Cell Death Differ 2015;22:826-37. [PMID: 25342470 DOI: 10.1038/cdd.2014.178] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
275 Kong M, Dong W, Zhu Y, Fan Z, Miao X, Guo Y, Li C, Duan Y, Lu Y, Li Z, Xu Y. Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury. Redox Biol 2021;46:102079. [PMID: 34454163 DOI: 10.1016/j.redox.2021.102079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
276 Waidmann O, Brunner F, Herrmann E, Zeuzem S, Piiper A, Kronenberger B. Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients. Liver Int 2016;36:1464-72. [DOI: 10.1111/liv.13117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
277 Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients. PLoS One 2012;7:e50289. [PMID: 23226258 DOI: 10.1371/journal.pone.0050289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
278 Ikura Y, Ohsawa M, Suekane T, Fukushima H, Itabe H, Jomura H, Nishiguchi S, Inoue T, Naruko T, Ehara S. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology. 2006;43:506-514. [PMID: 16496325 DOI: 10.1002/hep.21070] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 6.1] [Reference Citation Analysis]
279 Valverde AM, González-Rodríguez A. IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling. Arch Physiol Biochem 2011;117:105-15. [PMID: 21401320 DOI: 10.3109/13813455.2011.557386] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
280 Petrasek J, Csak T, Szabo G. Toll-like receptors in liver disease. Adv Clin Chem. 2013;59:155-201. [PMID: 23461136 DOI: 10.1016/b978-0-12-405211-6.00006-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
281 Romero-Palomo F, Festag M, Lenz B, Schadt S, Brink A, Kipar A, Steinhuber B, Husser C, Koller E, Sewing S, Tessier Y, Dzygiel P, Fischer G, Winter M, Hetzel U, Mihatsch MJ, Braendli-Baiocco A. Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats. Toxicol Pathol 2021;49:1174-92. [PMID: 34060347 DOI: 10.1177/01926233211011615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
282 Jung Y, Witek RP, Syn WK, Choi SS, Omenetti A, Premont R, Guy CD, Diehl AM. Signals from dying hepatocytes trigger growth of liver progenitors. Gut. 2010;59:655-665. [PMID: 20427400 DOI: 10.1136/gut.2009.204354] [Cited by in Crossref: 117] [Cited by in F6Publishing: 114] [Article Influence: 10.6] [Reference Citation Analysis]
283 Czaja AJ. Evolving paradigm of treatment for autoimmune hepatitis. Expert Review of Clinical Immunology 2017;13:781-98. [DOI: 10.1080/1744666x.2017.1319764] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
284 Czaja AJ. Targeting apoptosis in autoimmune hepatitis. Dig Dis Sci. 2014;59:2890-2904. [PMID: 25038736 DOI: 10.1007/s10620-014-3284-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
285 Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology. 2004;39:1230-1238. [PMID: 15122751 DOI: 10.1002/hep.20179] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 5.8] [Reference Citation Analysis]
286 Davies SP, Reynolds GM, Stamataki Z. Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis. Front Immunol 2018;9:44. [PMID: 29422896 DOI: 10.3389/fimmu.2018.00044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
287 Shen K, Feng X, Pan H, Zhang F, Xie H, Zheng S. Baicalin Ameliorates Experimental Liver Cholestasis in Mice by Modulation of Oxidative Stress, Inflammation, and NRF2 Transcription Factor. Oxid Med Cell Longev 2017;2017:6169128. [PMID: 28757911 DOI: 10.1155/2017/6169128] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
288 Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev. 2010;90:1165-1194. [PMID: 20664081 DOI: 10.1152/physrev.00061.2009] [Cited by in Crossref: 294] [Cited by in F6Publishing: 261] [Article Influence: 26.7] [Reference Citation Analysis]
289 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
290 Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Van de Water J, Gershwin ME. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. 2009;49:871-879. [PMID: 19185000 DOI: 10.1002/hep.22736] [Cited by in Crossref: 150] [Cited by in F6Publishing: 131] [Article Influence: 12.5] [Reference Citation Analysis]
291 Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008;48:670-678. [PMID: 18666225 DOI: 10.1002/hep.22399] [Cited by in Crossref: 136] [Cited by in F6Publishing: 143] [Article Influence: 10.5] [Reference Citation Analysis]
292 Salloum S, Holmes JA, Jindal R, Bale SS, Brisac C, Alatrakchi N, Lidofsky A, Kruger AJ, Fusco DN, Luther J, Schaefer EA, Lin W, Yarmush ML, Chung RT. Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types. Hepatology 2016;64:1951-68. [PMID: 27531241 DOI: 10.1002/hep.28766] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
293 Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni S, Lonardo A, Carulli N, Loria P. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol 2009;24:830-40. [PMID: 19207680 DOI: 10.1111/j.1440-1746.2008.05733.x] [Cited by in Crossref: 320] [Cited by in F6Publishing: 324] [Article Influence: 26.7] [Reference Citation Analysis]
294 Dong X, Liu J, Xu Y, Cao H. Role of macrophages in experimental liver injury and repair in mice. Exp Ther Med 2019;17:3835-47. [PMID: 31007731 DOI: 10.3892/etm.2019.7450] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
295 Selicean S, Wang C, Guixé-Muntet S, Stefanescu H, Kawada N, Gracia-Sancho J. Regression of portal hypertension: underlying mechanisms and therapeutic strategies. Hepatol Int 2021;15:36-50. [PMID: 33544313 DOI: 10.1007/s12072-021-10135-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]